tvpjournal.com | november/december 2015 | Today's VeTerinary PracTice
Today's VeTerinary news
19
Bundle includes:
ScanX Pro CR System,
PRO VECTA
HD
X-ray Generator,
TigerView Imaging Software,
1x IP 10"x12", 1x IP 14"x17",
Dental IPs: size 0, size 2, size 4
Metron Software option at
additional cost.
Full Body & Dental CR System
$23,490
Intra-oral X-ray Generator
$5,200
B u n d l e P r i c e
IDEXX BREAKTHROUGH KIDNEY FUNCTION TEST SDMA ADDED TO
IRIS STAGING GUIDELINES
IDEXX Laboratories, Inc has announced that the International Renal
Interest Society (IRIS) has added symmetric dimethylarginine (SDMA) to
their chronic kidney disease (CKD) staging guidelines. Since the SDMA
test became commercially available from IDEXX in July, more than
12,000 clinics have submitted over one million blood samples to IDEXX Reference Laboratories for SDMA
testing. Results from these tests show that SDMA has helped veterinarians detect early-stage kidney disease
in more than 90,000 cats and dogs when their creatinine values were still normal. The SDMA test is now
automatically included in all routine chemistry panels from IDEXX Reference Laboratories at no additional
cost. The IRIS CKD Staging Guidelines can be found at iris-kidney.com/guidelines.
PETCURE ONCOLOGY CHANGES LANDSCAPE FOR PETS WITH
PROSTATE CANCER
PetCure Oncology is taking the lead in providing an advanced form
of radiation therapy—Stereotactic Radiosurgery (SRS)—that is now
available to the veterinary community. Already proven successful in
human medicine, SRS delivers high doses of radiation with sub-
millimeter precision in a noninvasive, nonsurgical manner. In addition to treating the patient with the intent to
cure, SRS requires only 1 to 5 treatment sessions as opposed to 15 to 30 with conventional radiation therapy,
while minimizing both the risk and the side effects commonly associated with conventional treatment. Pets
with prostate cancer usually survive just weeks to months once they have been diagnosed. For afficted pets
and their families, this new treatment may provide an option that will improve outcomes. To learn more or
obtain a referral to PetCure Oncology, visit PetCureOncology.com.